Kiora Pharmaceuticals

Kiora Pharmaceuticals, Inc. is a clinical development-stage company located in Encinitas, California. The company employs 13 people and is publicly traded on the NASDAQ stock exchange under the ticker symbol KPRX. Kiora Pharmaceuticals focuses on developing new treatments for rare eye diseases known as orphan retinal diseases. These conditions often lack effective therapies, creating a significant need for new solutions. The company is dedicated to improving patient ocular health and restoring vision through its innovative research and development efforts. Kiora Pharmaceuticals distinguishes itself through its commitment to addressing the unmet needs of patients with orphan retinal diseases. By specializing in this area, the company can dedicate its expertise and resources to finding innovative therapies for these often-overlooked conditions. For more information about Kiora Pharmaceuticals, please visit their website at kiorapharma.com.